SCU joins forces with Genentech to improve skills of scientists through data-informed biomanufacturing.
Advanced data analytics can push promising medicines more quickly from idea to therapy. To help train the scientists charged with these breakthroughs, which could affect disorders including sickle cell anemia and Parkinson’s, SCU has partnered with Genentech to create the West Coast Biomanufacturing Consortium for Analytics and Data analytics (BioCAD). Its primary goal is improving the skills of working engineers and scientists, enabling them to make data-informed manufacturing decisions. The program is funded by a $300,000 grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals.
